Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Adamis Pharmaceuticals

Adamis Pharmaceuticals reported $9.08M in Assets for its fiscal quarter ending in March of 2023.

Assets Change
Adamis Pharmaceuticals ADMP:US USD 9.08M 1.85M
Adma Biologics ADMA:US USD 340.79M 7.67M
Brainstorm Cell Therapeutics BCLI:US USD 7.87M 579K
Cara Therapeutics CARA:US USD 153.28M 28.96M
GlaxoSmithKline GSK:LN GBP 58.6B 1.55B
Glaxosmithkline GSK:US GBP 58.6B 1.55B
RedHill Biopharma RDHL:US USD 158.87M 1.68M